European Immunization Week (EIW) is marked across the European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. ECDC supports the European Immunization Week campaign lead by WHO/Europe by providing scientific evidence on immunisation.
On 23 November WHO Europe published the results from the 5th annual meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC).
During the course of European Immunisation Week (EIW), 24 – 30 April 2016, ECDC is putting the spotlight on its resources in support of measles and rubella elimination. These range from disease surveillance and epidemic intelligence to communication tools and guides on awareness raising about the importance of vaccination, as well as the vaccination scheduler tool.
European Immunization Week (EIW) is celebrated across the European Region every April. It aims to raise awareness of the importance of immunization for people’s health and well-being. Activities in 2016 focused on the progress and challenges in the Region’s concerted effort to eliminate measles and rubella.
3 969 cases of measles were reported by 30 EU/EEA countries from 1 January to 31 December 2015, according to ECDC’s latest measles and rubella monitoring report. One measles-related death was reported in a 19 month old child, and six cases were complicated by acute measles encephalitis.
On the occasion of the tenth anniversary of European Immunization Week, ECDC is releasing a new complement of data, tools, blogs and updates to support public health authorities in their work against vaccine preventable diseases.
The summary of the the first intercountry meeting, held in Copenhagen on 24-25 March 2015, hosted jointly by WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) to address issues encountered by the national verfication committeees in European Union (EU)/European Economic Area (EEA) Member States.
This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
The goal of eliminating rubella and preventing CRS by 2015 could be achieved and maintained adopting a comprehensive approach to ensure high vaccination coverage.